Literature DB >> 10596264

Summary of the Practice Parameters for the Assessment and Treatment of Children, Adolescents, and Adults with Autism and other Pervasive Developmental Disorders. American Academy of Child and Adolescent Psychiatry.

F Volkmar, E Cook, J Pomeroy, G Realmuto, P Tanguay.   

Abstract

This summary provides an overview of the assessment and treatment recommendations contained in the Practice Parameters for the Assessment and Treatment of Children, Adolescents, and Adults With Autism and Other Pervasive Developmental Disorders. The parameters were written to aid clinicians in the assessment and treatment of children and adolescents with autism and other pervasive developmental disorders. Autism and the related pervasive developmental disorders are characterized by patterns of delay and deviance in the development of social, communicative, and cognitive skills, which arise in the first years of life. Although frequently associated with mental retardation, these conditions are distinctive in terms of their course and treatment. These conditions have a wide range of syndrome expression, and their management presents particular challenges for clinicians. Individuals with these conditions can present for clinical care at any point in development. The multiple developmental and behavioral problems associated with these conditions often require the care of multiple providers; coordination of services and advocacy for individuals and their families is important. Early, sustained intervention is indicated, as is the use of various treatment modalities (e.g., pharmacotherapy, special education, speech/communication therapy, and behavior modification.

Entities:  

Mesh:

Year:  1999        PMID: 10596264     DOI: 10.1097/00004583-199912000-00028

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  12 in total

1.  Legitimacy of comparing fragile X with autism questioned.

Authors:  Isabelle Rapin
Journal:  J Autism Dev Disord       Date:  2002-02

Review 2.  Review of Early Intervention for Children with Autism Spectrum Disorder: Focused on Randomized Controlled Trials.

Authors:  Young-Hui Yang
Journal:  Soa Chongsonyon Chongsin Uihak       Date:  2019-10-01

Review 3.  Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments.

Authors:  Jeremy Veenstra-VanderWeele; Randy D Blakely
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

4.  Examining autism spectrum disorders by biomarkers: example from the oxytocin and serotonin systems.

Authors:  Elizabeth Hammock; Jeremy Veenstra-VanderWeele; Zhongyu Yan; Travis M Kerr; Marianna Morris; George M Anderson; C Sue Carter; Edwin H Cook; Suma Jacob
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2012-05-26       Impact factor: 8.829

5.  Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6-17 years.

Authors:  Kelly Blankenship; Craig A Erickson; Kimberly A Stigler; David J Posey; Christopher J McDougle
Journal:  Ped Health       Date:  2010-09-29

6.  Aripiprazole to treat irritability associated with autism: a placebo-controlled, fixed-dose trial.

Authors:  Tami D Benton
Journal:  Curr Psychiatry Rep       Date:  2011-04       Impact factor: 5.285

Review 7.  The genetics of autism: key issues, recent findings, and clinical implications.

Authors:  Paul El-Fishawy; Matthew W State
Journal:  Psychiatr Clin North Am       Date:  2010-03

8.  Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric subjects (6-17 years old):results from a pooled analysis of 2 studies.

Authors:  Adelaide S Robb; Candace Andersson; Elizabeth E Bellocchio; George Manos; Carlos Rojas-Fernandez; Suja Mathew; Ronald Marcus; Randall Owen; Raymond Mankoski
Journal:  Prim Care Companion CNS Disord       Date:  2011

9.  Do hyperactivity, impulsivity and inattention have an impact on the ability of facial affect recognition in children with autism and ADHD?

Authors:  Judith Sinzig; Dagmar Morsch; Gerd Lehmkuhl
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-09-24       Impact factor: 4.785

Review 10.  Risperidone: a review of its use in the treatment of irritability associated with autistic disorder in children and adolescents.

Authors:  Lesley J Scott; Sohita Dhillon
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.